Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Head-and-Neck Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06894459
What this trial is testing

A Prospective, Multicenter, Multicohort Phase II Study: Evaluating the Efficacy and Safety of Preoperative Neoadjuvant Treatment With a PD-1 Inhibitor in Combination With Chemotherapy in Locally Advanced Laryngeal and Hypopharyngeal Squamous Cell Carcinoma

Who this might be right for
Head and Neck Cancers
Beijing Tongren Hospital 180
Early research (Phase 1)Active Not RecruitingNCT02567422
What this trial is testing

Testing the Addition of M6620 (VX-970, Berzosertib) to Usual Chemotherapy and Radiation for Head and Neck Cancer

Who this might be right for
Head and Neck Carcinoma of Unknown PrimaryHead and Neck Squamous Cell CarcinomaStage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7+9 more
National Cancer Institute (NCI) 43
Testing effectiveness (Phase 2)Looking for participantsNCT06959641
What this trial is testing

XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer

Who this might be right for
Locally Advanced Differentiated Thyroid Gland CarcinomaLocally Advanced Poorly Differentiated Thyroid Gland CarcinomaLocally Advanced Thyroid Gland Follicular Carcinoma+18 more
Jochen Lorch 33
Testing effectiveness (Phase 2)Study completedNCT01440270
What this trial is testing

Neo-adjuvant Erbitux-based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer

Who this might be right for
Locally Advanced Malignant NeoplasmOral CancerOropharyngeal Carcinoma
Shanghai Jiao Tong University School of Medicine 145
Testing effectiveness (Phase 2)Looking for participantsNCT06611137
What this trial is testing

SBRT Followed by Chemoimmunotherapy of Toripalimab Plus Docetaxel and Cisplatin for Larynx Preservation in Patients with Locally Regionally Advanced Squamous Cell Carcinoma of the Larynx and Hypopharynx

Who this might be right for
Laryngeal CancerHypopharynx Cancer
Sun Yat-sen University 35
Testing effectiveness (Phase 2)UnknownNCT04054518
What this trial is testing

Durvalumab as Maintenance Following Chemoradiation for Unresectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Tiago Biachi 22
Early research (Phase 1)Not Yet RecruitingNCT07034118
What this trial is testing

Definitive Proton Radiotherapy Combined With Chemotherapy and Immunotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Phase I Clinical Study

Who this might be right for
Esophageal Carcinoma
Anhui Provincial Hospital 23
Large-scale testing (Phase 3)UnknownNCT01212354
What this trial is testing

Impact of Selective Radiation Dose Escalation and Tumour Hypoxia Status on Locoregional Tumour Control After Radiochemotherapy of HNT

Who this might be right for
Locally Advanced Head and Neck Cancer
Technical University of Munich 270
Very early researchLooking for participantsNCT06828588
What this trial is testing

Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy

Who this might be right for
Locally Advanced CancerMetastatic CancerHER2+2 more
Vanderbilt-Ingram Cancer Center 30
Early research (Phase 1)Ended earlyNCT03727061
What this trial is testing

Porfimer Sodium Interstitial Photodynamic Therapy With or Without Standard of Care Chemotherapy in Treating Patients With Locally Advanced or Recurrent Head and Neck Cancer

Who this might be right for
Recurrent Head and Neck CarcinomaLocally Advanced Head and Neck Carcinoma
Roswell Park Cancer Institute 5
Testing effectiveness (Phase 2)Looking for participantsNCT06170710
What this trial is testing

Postoperative CCRT Followed by Immunotherapy in High-Risk LA HNSCC

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 173
Testing effectiveness (Phase 2)Looking for participantsNCT06709417
What this trial is testing

A Phase II Clinical Study of Sintilimab Combined with Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma (ESCC) (NICE-CS)

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Shanghai Chest Hospital 52
Testing effectiveness (Phase 2)UnknownNCT02429037
What this trial is testing

P53 Gene Combined With Radio- and Chemo-therapy in Treatment of Unresectable Locally Advanced Head and Neck Cancer

Who this might be right for
Advanced Head and Neck Cancer
Shenzhen SiBiono GeneTech Co.,Ltd 60
Testing effectiveness (Phase 2)Ended earlyNCT00493025
What this trial is testing

Paclitaxel, Cisplatin, Gefitinib, and Radiation Therapy Followed by Surgery and Gefitinib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction That Can Be Removed By Surgery

Who this might be right for
Esophageal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Early research (Phase 1)Looking for participantsNCT07503808
What this trial is testing

IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

Who this might be right for
Esophageal Squamous Cell CarcinomaHigh Grade Serous Ovarian CancerHead and Neck Squamous Cell Carcinoma+5 more
IDEAYA Biosciences 150
Large-scale testing (Phase 3)Study completedNCT00655876
What this trial is testing

Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer

Who this might be right for
Esophageal Cancer
Radiation Therapy Oncology Group 344
Testing effectiveness (Phase 2)Study completedNCT01592721
What this trial is testing

Radiation and Cetuximab Plus Intratumoral EGFR Antisense DNA in Locally Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Squamous Cell CarcinomaHead and Neck Cancer
The University of Texas Health Science Center at San Antonio 6
Testing effectiveness (Phase 2)WithdrawnNCT04106843
What this trial is testing

Radioactive Drug (177Lu-DOTATATE) for the Treatment of Locally Advanced, Metastatic, or Unresectable Rare Endocrine Cancers

Who this might be right for
Locally Advanced Adrenal Gland PheochromocytomaLocally Advanced ParagangliomaMetastatic Adrenal Gland Pheochromocytoma+11 more
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)UnknownNCT03924466
What this trial is testing

Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients

Who this might be right for
Metastatic Breast CarcinomaLocally Advanced Breast CancerCancer of Pancreas+11 more
Universitair Ziekenhuis Brussel 55
Testing effectiveness (Phase 2)Looking for participantsNCT05069857
What this trial is testing

Neoadjuvant Personalized Anti-PD-1 and Anti-VEGFR Therapy in OSCC Patients

Who this might be right for
Oral Squamous Cell CarcinomaNeoadjvant TherapyAnti-PD-1+1 more
Shanghai Jiao Tong University School of Medicine 46
Next Page